NCT04123236

Brief Summary

The patients who applied to the hospital for orthodontic treatment were asked various questions to evaluate their oral health related quality of life, malocclusions and self reported temporomandibular joint problems.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 10, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2020

Completed
Last Updated

December 3, 2019

Status Verified

December 1, 2019

Enrollment Period

1 year

First QC Date

October 2, 2019

Last Update Submit

December 2, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Oral Health Impact Profile

    Oral Health Impact Profile relations between patients under 18 and over 18 and between girls and boys

    through study completion, an average of 2 months. The scale ranged from 0-5. All data will be summed at the end of the study. Higher values means worse quality of life standard

  • Helkimo's anamnestic dysfunction index

    Helkimo's anamnestic dysfunction index relations between patients under 18 and over 18 and between girls and boys

    through study completion, an average of 2 months. The scale ranged from 0-3. Higher scale means worse quality of life standards

  • Helkimo's clinical dysfunction index

    Helkimo's clinical dysfunction index relations between patients under 18 and over 18 and between girls and boys

    through study completion, an average of 2 months. The scale ranged from 0-3. Higher scale means worse quality of life standards

  • Visual analog scale

    Visual analog scale relations between patients under 18 and over 18 and between girls and boys. The scale ranged from 0-1. If the patient marked no facial pain the visual analog scale value was accepted as 0, if the patient marked any level of facial pain visual analog scale value was accepted as 1.

    through study completion, an average of 2 months.

Study Arms (4)

Oral Health Impact Profile

To evaluate the Oral Health-related Quality of Life, Turkish version of Oral Health Impact Profile-14 was used. Responses were made on a scale 0 (never), 1(hardly ever), 2 (occasionally), 3 (fairly often),and 4 (very often).Oral Health-related Quality of Life impairment was characterized by the Oral Health Impact Profile-14 summary score (the sum of all 14 items, potential range 0-56). Higher Oral Health Impact Profile-14 scores mean worse Oral Health-related Quality of Life and vice versa.

Other: Age 0-18Other: Age 18-26Other: GirlsOther: Boys

Helkimo's anamnestic dysfunction index

As a method based on patient feedback for the determination of the degree of temporomandibular disorders, anamnestic index was used. For this purpose eight questions were asked to the patients that includes answers as 'yes' or 'no'. (Table 2) The analyses of the questionnaire was done according to anamnestic scale as 0: no symptoms; I: mild symptoms (sensation of the jaw fatigue, jaw stiffness, and temporomandibular joint sounds as clicking or crepitus) and II:severe symptoms (included one or more of the following: Difficulty in the mouth opening, jaw locking, mandible dislocation and its painful movement and painful temporomandibular joint region and/or masticatory muscles)

Other: Age 0-18Other: Age 18-26Other: GirlsOther: Boys

Visual analog scale (VAS) for facial pain:

Facial pain was measured by asking the patients if they had had any pain during last 12 months and made them mark the intensity of the pain on a visual analog scale which had the anchor points at the left (no pain) and right (worse pain) ends of a 10 cm horizontal line. The analyses of the facial pain was done as fallowing: if the patient marked no facial pain the Visual analog scale value was accepted as 0 and if the patient marked any level of facial pain Visual analog scale value was accepted as 1.

Other: Age 0-18Other: Age 18-26Other: GirlsOther: Boys

Helkimo's clinical dysfunction index (DI):

Maximum opening of mandible, deviation during opening, dysfunction of temporomandibular joint, pain in the temporomandibular joint and pain in the masticatory muscles was evaluated

Other: Age 0-18Other: Age 18-26Other: GirlsOther: Boys

Interventions

Patients under 18 years of age

Helkimo's anamnestic dysfunction indexHelkimo's clinical dysfunction index (DI):Oral Health Impact ProfileVisual analog scale (VAS) for facial pain:

Patients over18 years of age

Helkimo's anamnestic dysfunction indexHelkimo's clinical dysfunction index (DI):Oral Health Impact ProfileVisual analog scale (VAS) for facial pain:
GirlsOTHER

Girls

Helkimo's anamnestic dysfunction indexHelkimo's clinical dysfunction index (DI):Oral Health Impact ProfileVisual analog scale (VAS) for facial pain:
BoysOTHER

Boys

Helkimo's anamnestic dysfunction indexHelkimo's clinical dysfunction index (DI):Oral Health Impact ProfileVisual analog scale (VAS) for facial pain:

Eligibility Criteria

Age12 Years - 27 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Patients wish to receive orthodontic treatment in our clinic.

You may qualify if:

  • wish to receive orthodontic treatment in our clinic.

You may not qualify if:

  • The absence of willingness for the temporomandibular joint and clinical examination or answering the survey questions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep University

Gaziantep, Şehitkamil, 27310, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Interventions

lobo protein, Drosophila

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Merve Goymen, PhD

    University of Gaziantep

    STUDY CHAIR
  • Yeşim Kaya

    Yuzuncu Yil University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 2, 2019

First Posted

October 10, 2019

Study Start

July 10, 2018

Primary Completion

July 20, 2019

Study Completion

October 20, 2020

Last Updated

December 3, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations